Back to Search
Start Over
Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice
- Source :
- International Journal of Biological Sciences
- Publication Year :
- 2016
- Publisher :
- Ivyspring International Publisher, 2016.
-
Abstract
- Summary: PTH stimulates bone formation in Fgfr3 knockout mice through promotion of proliferation and differentiation in osteoblasts Introduction: Previous studies showed that endogenous fibroblast growth factor 2 (FGF-2) is required for parathyroid hormone (PTH)-stimulated bone anabolic effects, however, the exact mechanisms by which PTH stimulate bone formation and the function of FGF receptors in mediating these actions are not fully defined. FGF receptor 3 (FGFR3) has been characterized as an important regulator of bone metabolism and is confirmed to cross-talk with PTH/PTHrP signal in cartilage and bone development. Methods: Fgfr3 knockout and wild-type mice at 2-month-old and 4-month-old were intraperitoneally injected with PTH intermittently for 4 weeks and then the skeletal responses to PTH were assessed by dual energy X-ray absorptiometry (DEXA), micro-computed tomography (μCT) and bone histomorphometry. Results: Intermittent PTH treatment improved bone mineral density (BMD) and femoral mechanical properties in both Fgfr3-/- and wild-type mice. Histomorphometric analysis showed that bone formation and bone resorption were increased in both genotypes following PTH treatment. PTH treatment increased trabecular bone volume (BV/TV) in WT and Fgfr3-deficient mice. The anabolic response in Fgfr3-deficient and wild-type bone is characterized by an increase of both bone formation and resorption-related genes following PTH treatment. In addition, we found that Fgfr3 null osteoblasts (compared to wild-type controls) maintained normal abilities to response to PTH-stimulated increase of proliferation, differentiation, expression of osteoblastic marker genes (Cbfa1, Osteopontin and Osteocalcin), and phosphorylation of Erk1/2. Conclusions: Bone anabolic effects of PTH were not impaired by the absence of FGFR3, suggesting that the FGFR3 signaling may not be required for osteoanabolic effects of PTH activities. Refereed/Peer-reviewed
- Subjects :
- 0301 basic medicine
musculoskeletal diseases
Male
medicine.medical_specialty
Blotting, Western
Parathyroid hormone
Real-Time Polymerase Chain Reaction
Applied Microbiology and Biotechnology
Bone resorption
Bone remodeling
03 medical and health sciences
Mice
Bone Density
Internal medicine
medicine
Animals
Receptor, Fibroblast Growth Factor, Type 3
Osteopontin
Molecular Biology
bone remodeling
Ecology, Evolution, Behavior and Systematics
Cells, Cultured
Bone mineral
Mice, Knockout
Osteoblasts
biology
Chemistry
Osteoblast
Cell Biology
Fibroblast growth factor receptor 3
030104 developmental biology
medicine.anatomical_structure
Endocrinology
FGFR3
Parathyroid Hormone
osteoblast
Osteocalcin
biology.protein
knockout mice
hormones, hormone substitutes, and hormone antagonists
Developmental Biology
Research Paper
PTH
Knockout mice
Subjects
Details
- Language :
- English
- ISSN :
- 14492288
- Volume :
- 12
- Issue :
- 8
- Database :
- OpenAIRE
- Journal :
- International Journal of Biological Sciences
- Accession number :
- edsair.doi.dedup.....9d15661579b6f00f32a509bcc5ad5ce2